Pharmaceutical Composition
Patent No. EP3222272 (titled "Pharmaceutical Composition") was filed by Ferring on Sep 29, 2011. The application was issued on Nov 3, 2021.
Patent Summary
A pharmaceutical composition for preventing postpartum hemorrhage (PPH) comprising carbetocin or a pharmaceutically active salt thereof, characterized by a pH range of 5.26 to 5.65, which enables room temperature stability for up to two years, allowing for use in ambulances and tropical regions.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
EP3222272
- Application Number
- EP17169328A
- Filing Date
- Sep 29, 2011
- Status
- Granted And Under Opposition
- Oct 1, 2021
- Publication Date
- Nov 3, 2021
- External Links
- Slate, Register , Google Patents